PharmaMatrix Holdings Ltd
PharmaMatrix Holdings Ltd
Explore linked clinical trials.1 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| A Phase I Open-Label, Single-Arm, Dose-Escalation Clinical and Pharmacology Study of CCI-001 as Monotherapy and in Combination With Standard Chemotherapy in Patients With Recurrent and/or Metastatic Solid Tumours | Cancer: Recurrent and/or Metastatic Solid Tumours | Recruiting | Phase 1 | 2026-03-19 | NCT04823897 |